The biotech is evaluating several cystic fibrosis medicines that could either work alongside Vertex’s top-selling Trikafta or ...

Despite new medication, cystic fibrosis often leads to permanent lung damage. Working with an international team, researchers ...

Embarking on this high-altitude adventure, given my severe chronic illness, was challenging but completely worth it ...

Researchers have been trying for decades to stop the cells that damage the lung in people with pulmonary fibrosis. Now a team ...

Pembrokeshire’s intrepid Atlantic rowers have finally launched into the ocean for their 3,200-mile challenge.

Israeli forces shut down the crossing in early May after seizing it during an offensive on the southern city, causing Egypt ...

Vertex Pharmaceuticals (NASDAQ:VRTX), a global biotechnology company with a market capitalization of $119.1 billion known for its transformative cystic fibrosis (CF) treatments, finds itself at a ...

Sophie would make a world record for being the first man or woman with cystic fibrosis to row across the Atlantic, while at ...

Collaborative Discovery Programme (CDP) funding introduced by the Cystic Fibrosis Antimicrobial Resistance (CF AMR) Syndicate. The funding of up to £500,000 is provided by LifeArc, a medical research ...

In 2024, Boss Fight Books released a book on Animal Crossing, written by game historian Kelsey Lewin, exploring how this all began. Below, as part of Polygon’s Culture Shock special issue ...

In December, the FDA approved Vertex’s vanzacaftor, tezacaftor and deutivacaftor (Alyftrek) for the treatment of cystic fibrosis in patients with at least one F508del mutation or another ...